A bispecific antibody targeting CLDN18.2 and 4-1BB induces potent anti-tumor efficacy with an extraordinary safety profile

被引：0
|
作者：
Chen, Junying [1 ]
Huang, Weifeng [2 ]
Liang, Zhiquan [1 ]
Miao, Xiaoniu [1 ]
Peng, Shaogang [2 ]
Wang, Chao [1 ]
Dong, Tiantian [1 ]
Tsun, Andy [1 ]
Luo, Yi [1 ]
机构：
[1] Biotheus Inc, Zhuhai, Peoples R China
[2] Biotheus Suzhou Co Ltd, Suzhou, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5555
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation
    Chiu, Danica
    Tavare, Richard
    Haber, Lauric
    Aina, Olulanu H.
    Vazzana, Kristin
    Ram, Priyanka
    Danton, Makenzie
    Finney, Jennifer
    Jalal, Sumreen
    Krueger, Pamela
    Giurleo, Jason T.
    Ma, Dangshe
    Smith, Eric
    Thurston, Gavin
    Kirshner, Jessica R.
    Crawford, Alison
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (05) : 596 - 608
  • [22] ATG-101, A NOVEL PD-L1/4-1BB BISPECIFIC ANTIBODY, AUGMENTS ANTI-TUMOR IMMUNITY THROUGH IMMUNE CHECKPOINT INHIBITION AND PDL1-DIRECTED 4-1BB ACTIVATION
    Hui Yuwen
    Li, Tengteng
    Ren, Yijing
    Hoenemann, Dirk
    Mei, Jay
    Shan, Bo
    Hou, Bing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A936 - A937
  • [23] BH3120: A novel bispecific antibody targeting 4-1BB and PD-L1 with well balanced efficacy and safety profiles.
    Xu, Jiangcheng
    Liu, Yang
    Wang, Jing
    Fan, Fei
    Gu, Haitao
    Zhang, Lanxin
    Wang, Jun
    Song, Ding
    Guo, Ailong
    Zhang, Hongjuan
    Su, Kaixuan
    Su, Jiaojiao
    Li, Lijuan
    Cai, Jingmei
    Zhang, Aihong
    Liu, Jiawang
    Lee, Kyoungwoo
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Preclinical safety and efficacy of a tumor-directed T cell activating 4-1BB x 5T4 ADAPTIR™ bispecific antibody
    Dahlman, Anna
    Nelson, Michelle
    Bannink, Jeannette
    Johnson, Starrla
    Werchau, Doreen
    Nilsson, Anneli
    Ljung, Lill
    Blahnik-Fagan, Gabriele
    Bader, Robert
    Deronic, Adnan
    Ellmark, Peter
    Askmyr, Maria
    Hernandez-Hoyos, Gabriela
    McMahan, Cathy
    Fritzell, Sara
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
    Liao, Tzu-Yi
    Liu, Yen-Ling
    Chen, Chiao-Yun
    Wu, Bing-Tsung
    Liu, En-Shuo
    Hong, Shih-Ting
    Huang, Bo-Cheng
    Cheng, Yi-An
    Chen, Michael
    Chuang, Kuo-Hsiang
    Lin, Wen-Wei
    Chuang, Chih-Hung
    Chen, Fang-Ming
    Ho, Kai-Wen
    Cheng, Tian-Lu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 305
  • [26] A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
    Marta Compte
    Seandean Lykke Harwood
    Ines G. Muñoz
    Rocio Navarro
    Manuela Zonca
    Gema Perez-Chacon
    Ainhoa Erce-Llamazares
    Nekane Merino
    Antonio Tapia-Galisteo
    Angel M. Cuesta
    Kasper Mikkelsen
    Eduardo Caleiras
    Natalia Nuñez-Prado
    M. Angela Aznar
    Simon Lykkemark
    Jorge Martínez-Torrecuadrada
    Ignacio Melero
    Francisco J. Blanco
    Jorge Bernardino de la Serna
    Juan M. Zapata
    Laura Sanz
    Luis Alvarez-Vallina
    Nature Communications, 9
  • [27] A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
    Compte, Marta
    Lykke Harwood, Seandean
    Munoz, Ines G.
    Navarro, Rocio
    Zonca, Manuela
    Perez-Chacon, Gema
    Erce-Llamazares, Ainhoa
    Merino, Nekane
    Tapia-Galisteo, Antonio
    Cuesta, Angel M.
    Mikkelsen, Kasper
    Caleiras, Eduardo
    Nunez-Prado, Natalia
    Aznar, M. Angela
    Lykkemark, Simon
    Martinez-Torrecuadrada, Jorge
    Melero, Ignacio
    Blanco, Francisco J.
    Bernardino de la Serna, Jorge
    Zapata, Juan M.
    Sanz, Laura
    Alvarez-Vallina, Luis
    NATURE COMMUNICATIONS, 2018, 9
  • [28] ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy
    Dahlen, Eva
    Rosen, Anna
    Barchan, Karin
    Dahlman, Anna
    Ellmark, Peter
    Furebring, Tina
    Smith, Karin Enell
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [29] Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
    Timothy S. Fisher
    Cris Kamperschroer
    Theodore Oliphant
    Victoria A. Love
    Paul D. Lira
    Regis Doyonnas
    Simon Bergqvist
    Sangita M. Baxi
    Allison Rohner
    Amy C. Shen
    Chunli Huang
    Sharon A. Sokolowski
    Leslie L. Sharp
    Cancer Immunology, Immunotherapy, 2012, 61 : 1721 - 1733
  • [30] Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
    Fisher, Timothy S.
    Kamperschroer, Cris
    Oliphant, Theodore
    Love, Victoria A.
    Lira, Paul D.
    Doyonnas, Regis
    Bergqvist, Simon
    Baxi, Sangita M.
    Rohner, Allison
    Shen, Amy C.
    Huang, Chunli
    Sokolowski, Sharon A.
    Sharp, Leslie L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1721 - 1733
12345